BTLA Peptide | 46-766P

BTLA Peptide | 46-766P | Gentaur UK, US & Europe Distribution

Short Description: BTLA Peptide

Species: Mouse

Location: BTLA peptide corresponds to 14 amino acids of BTLA.

Tested Application: Bl

Application: BTLA Peptide is used for blocking the activity of BTLA antibody (catalog number 46-766). The BTLA antibody ships at 0.5 mg/mL and the BTLA Peptide ships as a 100 ug pellet. When peptide is reconstituted in 200 uL water, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.

Physical State: Lyophilized

Buffer: BTLA peptide is supplied as 100 μg of dried peptide. When the peptide is reconstituted in 200 μL water, the concentration will be 0.5 mg/mL.

Concentration: N/A

Storage: Store at -20˚C. When reconstituted minimize freezing and thawing.

NCBI Official Symbol: BTLA

Alternate Names: BTLA1, CD272, B- and T-lymphocyte attenuator, B- and T-lymphocyte-associated protein,

NCBI Gene ID: 151888

User Note: N/A

NCBI Official Name: B And T Lymphocyte Associated

Background: N/A

Disclaimer: This product is for research use only.